
Tonbo Imaging India opened its ₹852.18 crore IPO for subscription on October 15, 2026, with shares offered at ₹665 to ₹700 per share. The issue saw a subscription of 0.19 times as of 10:12 AM on day 1.
Investors can bid for the IPO until October 19, 2026. The basis of allotment is expected to be finalised on October 21, while the company’s shares are scheduled to list on the BSE and NSE on October 23, 2026, subject to the proposed timeline.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
15 October 2026 |
|
Subscription Closing Date |
19 October 2026 |
|
Basis of Allotment Date |
21 October 2026 |
|
Refund Initiation Date |
22 October 2026 |
|
Credit of Shares |
22 October 2026 |
|
Listing on BSE and NSE |
23 October 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[October 15, 2026, 10:12 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.00x |
|
Non-Institutional Investors (NIIs) |
0.43x |
|
Retail Individual Investors (RIIs) |
0.19x |
|
Employees |
0.32x |
|
Total |
0.19x |
Founded in 2003, Tonbo Imaging India Limited manufactures defence electronics, with a focus on thermal imaging, surveillance, target acquisition and missile guidance systems. The company caters to defence clients in India and overseas, offering technologies based on electro-optics, infrared imaging and embedded vision.
As of June 30, 2026, Tonbo Imaging had deployed over 28,000 systems in 24 countries. Its electro-optical and infrared (EO/IR) products fall outside the scope of US International Traffic in Arms Regulations (ITAR), providing greater flexibility in supplying international markets subject to export-control rules.
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
36.01 |
362.65 |
469.08 |
|
EBITDA |
(13.04) |
104.62 |
139.06 |
|
Profit After Tax (PAT) |
(17.74) |
50.89 |
72.76 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here